Lazard (LAZ) has just posted its Q1 2026 update, with the most recent full quarter of detail showing Q4 2025 revenue of US$892.6 million and basic EPS of US$0.49, alongside trailing twelve month revenue of about US$3.1 billion and EPS of US$2.37. Over the past few reported quarters, revenue has moved from US$811.4 million in Q4 2024 to US$892.6 million in Q4 2025, while basic EPS shifted from US$0.89 to US$0.49. This sets up a results season where revenue scale and pressure on per share earnings sit side by side for investors watching margins.

See our full analysis for Lazard.

With the headline numbers on the table, the next step is to see how this mix of revenue strength and tighter margins lines up against the prevailing Lazard narratives that investors follow most closely.

Margins Squeezed Despite Revenue Scale

• Lazard generated about US$3.1b of trailing twelve month revenue with a 7.5% net profit margin, compared with 9% the prior year, so a larger top line is currently translating into a smaller share of profit.
• Bulls point out that analysts expect revenue to grow around 13% per year and margins to move higher over time. However, the recent margin slip from 9% to 7.5% highlights that the starting point is weaker than the bullish view of improving profitability suggests.
  • For a bullish thesis built on higher profitability, the current 7.5% margin needs to move a long way toward the higher margin levels that optimistic scenarios reference.
  • Until that gap closes, the recent compression in margins keeps the bullish story more dependent on future execution than on what the last twelve months show.

Revenue momentum with softer margins is exactly the kind of mixed picture bulls debate, so if you want to see how bullish investors connect recent results to their outlook, check out the 🐂 Lazard Bull Case.

Five year earnings slide at 23.5% a year

• Over the past five years, earnings have declined at an annualized rate of 23.5%, which contrasts sharply with the trailing twelve month revenue base of around US$3.1b.
• Bears argue that this 23.5% yearly earnings drop shows structural pressure on profitability, and the multi year decline means that even if analysts model higher margins ahead, the burden of proof sits with Lazard to turn a long earnings slide into the kind of growth the more cautious forecasts still assume.
  • The fact that earnings have fallen at 23.5% per year while recent margins sit at 7.5% underlines that profitability has been under pressure for an extended period, not just a single year.
  • This history feeds the bearish concern that higher future earnings estimates depend on a reversal of a trend that has persisted over several years.

Skeptical investors often focus on that long earnings decline, so if you want to see how the cautious narrative frames these risks, take a look at the 🐻 Lazard Bear Case.

Discounted share price against DCF value

• With the share price at US$45.13 and a DCF fair value of about US$96.75, the stock is trading at less than half of that modelled value while also sitting on an 18.4x P/E versus 41.9x for the US Capital Markets industry and 24.5x for peers.
• Consensus narrative treats this gap as potential value support, but the same data set flags high debt and an unstable dividend history, so the low P/E and discount to DCF fair value sit alongside balance sheet and payout risks rather than a clean value story.
  • The 18.4x P/E looks modest next to the 41.9x industry and 24.5x peer averages, which aligns with the idea that expectations are more muted.
  • However, the combination of high leverage and a patchy dividend record shows that part of the discount could reflect financial risk as well as any perceived opportunity.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Lazard on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals on earnings, margins and valuation can pull you in different directions. Move quickly, review the data yourself, and weigh the 2 key rewards and 3 important warning signs.

See What Else Is Out There

Lazard faces a mix of squeezed margins, a multi year 23.5% earnings decline, and balance sheet concerns that leave its value case carrying extra risk.

If those pressure points give you pause, compare this profile with companies in the 69 resilient stocks with low risk scores to quickly spot businesses where financial risk scores look more comfortable.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.